Improved survival in MDS patients receiving iron chelation therapy - A matched pair analysis of 188 patients from the Dusseldorf MDS registry
Leukemia Research, 06/26/2012
Neukirchen J et al. – The difference in median survival supports the idea that iron chelation therapy is beneficial for myelodysplastic syndrome (MDS) patients.



